Siddappa N. Byrareddy

University of Nebraska Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Shetty Ravi Dyavar

UNITED STATES

View details

Christian Lorson

University of Missouri

UNITED STATES

View details

Kamalendra Singh

Assistant Professor

University of Missouri

UNITED STATES

View details

Dario Ghersi

University of Nebraska - Lincoln

UNITED STATES

View details

Samuel Johnson

University of Pittsburgh

UNITED STATES

View details

Sean Avedissian

Assistant Professor

University of Nebraska Medical Center

UNITED STATES

View details

Courtney V. Fletcher

University of Nebraska Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Siddappa N. Byrareddy

Research Interests

Explore related searches

Contact this professor

Articles (11)

Dual role for microbial short-chain fatty acids in modifying SIV disease trajectory following anti-α4β7 antibody administration

ACE-2, TMPRSS2, and Neuropilin-1 Receptor Expression on Human Brain Astrocytes and Pericytes and SARS-CoV-2 Infection Kinetics

Engineering an ACE2-Derived Fragment as a Decoy for Novel SARS-CoV-2 Virus

Cannabinoid enhancement of lncRNA MMP25-AS1/MMP25 interaction reduces neutrophil infiltration and intestinal epithelial injury in HIV/SIV infection

Complex Mutation Pattern of Omicron BA.2: Evading Antibodies without Losing Receptor Interactions

The 2022 outbreak and the pathobiology of the monkeypox virus

Chronic Opioid Administration is Associated with Prevotella-dominated Dysbiosis in SIVmac251 Infected, cART-treated Macaques

Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection

HIV‐associated dysbiosis and immune recovery during antiretroviral therapy

PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron

SAP30, an oncogenic driver of progression, survival, and drug resistance in high-risk neuroblastoma

Collaborators (7)

Shetty Ravi Dyavar

Christian Lorson

Kamalendra Singh

Dario Ghersi

Samuel Johnson

Sean Avedissian

Courtney V. Fletcher

Make your next move.